It is now appreciated that bacterial lipopolysaccharides (LPS) are responsible for initiating the pathophysiologic changes occurring in patients with gram-negative septicemia. The high mortality rate in this group of patients contributes to one of leading causes of death in the United States. The long range goal of this renewal proposal is to define the biochemical mechanisms of LPS interactions with key plasma proteins and tissue-fixed cells and to relate the interactions to the development of injury. The proposed studies will focus specifically on three areas: (i) studies of the mechanism of interaction of LPS with normal and acute phase serum paying particular attention to the regulation of LPS-high density lipoprotein (HDL) binding and to structure/function studies of the LPS-HDL complex, (ii) investigation of how cells recognize the presence of LPS by specifically characterizing the cell membrane components which interact with LPS and lead to cell activation, and (iii) characterization of the enzymatic mechanisms in the macrophage which lead to arachidonic acid release with specific emphasis on the isolation and characterization of phospholipases which catalyze arachidonic acid release from phospholipid. In addition to the relevance of the proposed studies to understanding the mechanism of action of LPS, these studies will provide more general information about the role of acute phase reactants in regulating the host response to inflammatory stimuli, about the molecular basis of the early steps of B-cell activation and about the properties of the phospholipases which may control the production of potent mediators (prostaglandins and leukotrienes) of injury in a wide variety of pathologic conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015136-10
Application #
3126032
Study Section
Pathology A Study Section (PTHA)
Project Start
1978-08-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
10
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
da Silva Correia, J; Miranda, Y; Leonard, N et al. (2007) Regulation of Nod1-mediated signaling pathways. Cell Death Differ 14:830-9
da Silva Correia, Jean; Miranda, Yvonne; Leonard, Nikki et al. (2007) The subunit CSN6 of the COP9 signalosome is cleaved during apoptosis. J Biol Chem 282:12557-65
da Silva Correia, Jean; Miranda, Yvonne; Leonard, Nikki et al. (2007) SGT1 is essential for Nod1 activation. Proc Natl Acad Sci U S A 104:6764-9
da Silva Correia, Jean; Miranda, Yvonne; Austin-Brown, Nikki et al. (2006) Nod1-dependent control of tumor growth. Proc Natl Acad Sci U S A 103:1840-5
Pan, Qilin; Kravchenko, Vladimir; Katz, Alex et al. (2006) NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway. Infect Immun 74:2121-7
Han, Jiahuai; Ulevitch, Richard J (2005) Limiting inflammatory responses during activation of innate immunity. Nat Immunol 6:1198-205
Chuang, Tsung-Hsien; Ulevitch, Richard J (2004) Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 5:495-502
Ulevitch, Richard J (2003) Regulation of receptor-dependent activation of the innate immune response. J Infect Dis 187 Suppl 2:S351-5
da Silva Correia, Jean; Ulevitch, Richard J (2002) MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 277:1845-54
Sanna, M Germana; da Silva Correia, Jean; Luo, Ying et al. (2002) ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J Biol Chem 277:30454-62

Showing the most recent 10 out of 79 publications